| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protection of telomeres 1 | 0.560 | 0.731 | 0.85 |
|
disease | 0.640 | None | 1.000 | 1 | 1 | 2013 | 2018 | ||||||||
|
interferon regulatory factor 4 | 0.491 | 0.769 | 0.86 |
|
disease | 0.500 | None | 0.933 | 4 | 2 | 2008 | 2019 | ||||||||
|
lymphoid enhancer binding factor 1 | 0.486 | 0.769 | 1.00 |
|
disease | 0.500 | None | 1.000 | 1 | 2 | 2005 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.500 | None | 0.974 | 1 | 3 | 1987 | 2020 | ||||||||
|
SP140 nuclear body protein | 0.691 | 0.577 | 5.0E-08 |
|
disease | 0.430 | None | 1.000 | 4 | 1 | 2008 | 2017 | ||||||||
|
acyl-CoA oxidase like | 0.674 | 0.577 | 5.2E-15 |
|
disease | 0.410 | None | 1.000 | 4 | 3 | 2008 | 2017 | ||||||||
|
FERM, ARH/RhoGEF and pleckstrin domain protein 2 | 0.678 | 0.615 | 4.6E-36 |
|
disease | 0.410 | None | 1.000 | 2 | 1 | 2010 | 2013 | ||||||||
|
protein kinase D2 | 0.666 | 0.538 | 1.00 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2008 | 2008 | ||||||||
|
glutaminyl-peptide cyclotransferase | 0.568 | 0.731 | 1.2E-15 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2013 | 2016 | ||||||||
|
chromosome 11 open reading frame 21 | 0.821 | 0.192 | 1.6E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2013 | 2017 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.180 | None | 1.000 | 1 | 3 | 1993 | 2017 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.160 | None | 1.000 | 1 | 1 | 2001 | 2019 | ||||||||
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
disease | 0.120 | None | 1.000 | 2 | 1 | 2012 | 2019 | ||||||||
|
interferon regulatory factor 8 | 0.539 | 0.808 | 0.95 |
|
disease | 0.110 | None | 1.000 | 4 | 3 | 2011 | 2014 | ||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2008 | 2017 | |||||||||
|
GRAM domain containing 1B | 0.736 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2008 | 2017 | ||||||||
|
downregulated RNA in cancer, inhibitor of cell invasion and migration | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2008 | 2017 | |||||||||
|
gametogenetin binding protein 1 (pseudogene) | 0.769 | 0.462 | 0.69 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2017 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2010 | 2017 | |||||||||
|
cancer susceptibility 19 | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2010 | 2017 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
fukutin related protein | 0.513 | 0.731 | 9.8E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
regulatory factor X7 | 0.780 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 |